Intuitive receives CE mark for transvaginal use of da Vinci SP system
September 20, 2026
The approval allows the da Vinci SP system to be utilised in more women’s health procedures across Europe.
The approval allows the da Vinci SP system to be utilised in more women’s health procedures across Europe.
NORCROSS, Ga., Sept. 18, 2026 /PRNewswire/ — Koning Health, a global leader in advanced breast imaging technology, today announced that the Koning Breast CT System has been successfully included in the Australian Register of Therapeutic Goods (ARTG), marking an important regulatory milestone for the company’s expansion into the Australian market.
Researchers have developed a 3D map of an ovary for the first time, enabling a deeper understanding of how and when oocytes — immature eggs — are activated. Published in the journal Nature Aging, the team believes their findings have important implications for human reproductive health, as well as opening the door to future studies.
The FDA has given the go-ahead to Ultragenyx’s rebisufligene etisparvovec—now to be marketed under the brand name Fayuvi—for the treatment of Sanfilippo syndrome type A, an ulta-rare, progressive neurological condition in children.
The rete ovarii (RO) is a small structure attached directly to the ovary that has largely faded from view since it was first described more than a century ago. Its name comes from the Latin word for “network,” referring to the interconnected tubes and channels that make up the structure, according to the National Cancer Institute.
A simple method involving local anesthesia in the uterus can reduce pain during IUD insertion, according to a new study from Karolinska Institutet, published in the journal JAMA. The method also increased the proportion of women who found the procedure tolerable. The results may encourage more women to choose an IUD as a contraceptive method.
A new study published in the journal npj Breast Cancer demonstrates that an artificial intelligence (AI) model offers more accurate predictions of recurrence risk in patients with early-stage breast cancer than the widely used 21-gene Recurrence Score. This research, conducted by a team from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Caris Life Sciences, specifically targets hormone receptor-positive (HR+) and HER2-negative disease, the most common subtype of breast cancer, which accounts for about half of all breast cancer cases in the United States.
Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast cancer therapy using pulsed electromagnetic fields (PEMFs). The NUS team successfully reprogrammed tumor-associated macrophages (TAMs), a corrupted class of immune cells that typically promote cancer growth, into an active anti-tumor state that attacks and destroys cancer cells.
Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell is a long battle in drug development and in designing effective treatments. A new AI tool called ProteinTalks makes this task easier by accurately predicting whether a drug will be effective against a cancer cell line, finding new drug combinations and identifying proteins linked to drug resistance.
Pelvic organ prolapse is a common but often overlooked condition that affects millions of women. It occurs when the tissues that support the pelvic organs weaken, allowing organs such as the bladder, uterus or rectum to shift from their normal position. Doctors can assess how severe the prolapse is, but existing tools do not provide much information about what’s happening inside the tissue itself.